THE PATH FORWARD: ADVANCING TREATMENTS AND CURES FOR NEURODEGENERATIVE DISEASES

Today, Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, testified before the Health Subcommittee of the Energy and Commerce Committee. I asked her to share if there has been anyone able to access treatments in trials to treat ALS and other neurodegenerative diseases. #ALS#medicalresearch#prescriptiondrugs#FDA